Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN. REBORN Study

NCT04464122 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT04464122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04464122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN. REBORN Study
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Recruiting
Start date
September 14, 2020
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine carcinoma, neuroendocrine neoplasm, neuroendocrine tumor grade 1, neuroendocrine tumor grade 2, neuroendocrine tumors